Antithrombotic agents in coronary artery disease.

Suppr

超能文献

作者信息

Cairns J A, Théroux P, Lewis H D, Ezekowitz M, Meade T W, Sutton G C

机构信息

Faculty of Medicine, University of British Columbia, Vancouver, Canada.

出版信息

Chest. 1998 Nov;114(5 Suppl):611S-633S. doi: 10.1378/chest.114.5_supplement.611s.

DOI:10.1378/chest.114.5_supplement.611s

PMID:9822067

Abstract

摘要

相似文献

Antithrombotic agents in coronary artery disease.

Chest. 1998 Nov;114(5 Suppl):611S-633S. doi: 10.1378/chest.114.5_supplement.611s.

Antithrombotic agents in coronary artery disease.

Chest. 1986 Feb;89(2 Suppl):54S-67S. doi: 10.1378/chest.89.2_supplement.54s.

[Coronary insufficiency and heparin].[冠状动脉供血不足与肝素]

Arq Bras Cardiol. 1991 Aug;57(2):141-50.

Antithrombotic agents in coronary artery disease.冠状动脉疾病中的抗血栓形成药物。

Chest. 1989 Feb;95(2 Suppl):52S-72S. doi: 10.1378/chest.95.2_supplement.52s.

Antithrombotic agents in coronary artery disease.

Chest. 1992 Oct;102(4 Suppl):456S-481S. doi: 10.1378/chest.102.4_supplement.456s.

Introduction: Expanding the horizons in unstable coronary artery disease.引言：拓展不稳定型冠状动脉疾病的视野。

Clin Cardiol. 2000 Jan;23 Suppl 1(Suppl):I1-3. doi: 10.1002/clc.4960231302.

Antithrombotic therapy for acute myocardial infarction: mechanisms and prevention of deep venous, left ventricular, and coronary artery thromboembolism.

Circulation. 1986 Nov;74(5 Pt 2):III1-10.

Clinical potential of antithrombotic drugs in coronary syndromes.

Am J Cardiol. 1998 Sep 10;82(5B):11L-14L. doi: 10.1016/s0002-9149(98)00106-4.

Antithrombotic therapy in the primary and secondary prevention of coronary-related death and infarction: focus on gender differences.冠状动脉相关死亡和梗死一级及二级预防中的抗栓治疗：关注性别差异。

Cardiology. 1990;77 Suppl 2:99-109. doi: 10.1159/000174658.

[Coronary insufficiency and heparin].[冠状动脉供血不足与肝素]

Arq Bras Cardiol. 1992 Jan;58(1):51-61.

引用本文的文献

Prevention of cardioembolic stroke.预防心源性脑卒。

Neurotherapeutics. 2011 Jul;8(3):488-502. doi: 10.1007/s13311-011-0048-y.

Use of antithrombotic agents among U.S. stroke survivors, 2000-2006.美国卒中幸存者中抗血栓药物的使用情况，2000-2006 年。

Am J Prev Med. 2010 Jan;38(1):47-53. doi: 10.1016/j.amepre.2009.08.029.

Arterial indications for the low molecular weight heparins.低分子量肝素的动脉适应症。

Curr Control Trials Cardiovasc Med. 2001;2(5):233-239. doi: 10.1186/cvm-2-5-233.

Left Ventricular Thrombus.左心室血栓

Curr Treat Options Cardiovasc Med. 2001 Dec;3(6):515-521. doi: 10.1007/s11936-001-0025-6.

Low-molecular weight heparins in coronary artery disease.低分子量肝素在冠状动脉疾病中的应用

Curr Atheroscler Rep. 2001 Mar;3(2):163-8. doi: 10.1007/s11883-001-0053-4.

Clopidogrel: a review of its use in the prevention of atherothrombosis.氯吡格雷：其在预防动脉粥样硬化血栓形成中的应用综述

Drugs. 2000 Aug;60(2):347-77. doi: 10.2165/00003495-200060020-00012.

Low molecular weight heparins and coronary artery disease.

Curr Cardiol Rep. 2000 Jan;2(1):61-8. doi: 10.1007/s11886-000-0027-0.

Dalteparin: an update of its pharmacological properties and clinical efficacy in the prophylaxis and treatment of thromboembolic disease.达肝素：其在预防和治疗血栓栓塞性疾病方面的药理特性及临床疗效的最新进展

Drugs. 2000 Jul;60(1):203-37. doi: 10.2165/00003495-200060010-00010.

Determination of who may derive most benefit from aspirin in primary prevention: subgroup results from a randomised controlled trial.确定谁可能从阿司匹林一级预防中获益最大：一项随机对照试验的亚组结果

BMJ. 2000 Jul 1;321(7252):13-7. doi: 10.1136/bmj.321.7252.13.

Low-molecular-weight heparin should replace unfractionated heparin in the management of acute coronary syndromes.

J Thromb Thrombolysis. 1999 Aug;8(2):79-87. doi: 10.1023/a:1008908400133.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验